SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Best Magic Formula Stocks 2026

Joel Greenblatt’s magic formula identifies undervalued stocks with strong profitability based on earnings yield and return on capital (ROC). Discover top magic formula stocks and build a high-growth portfolio. Explore the list now! Joel Greenblatt’s magic formula identifies undervalued stocks with strong profitability based on earnings yield and return on capital (ROC). Discover top magic formula stocks and build a high-growth portfolio. Explore the list now!

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Best Magic Formula Stocks 2026 as on Apr-2026 | 25 companies found

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	P/E	P/BV	EV/ EBITDA	5Y Profit Gr.(%)
1	Tata Consultancy Services Ltd	Q V+ PT	2,397	-4.97%	9,12,681 -	3,630 12 May, 25	2,346 30 Mar, 26	18.55	8.50	11.72	9.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Life Insurance Corporation of India	Q V+ PT	811	-0.10%	5,13,527 -	980 30 Jun, 25	722 02 Apr, 26	9.69	3.36	7.59	77.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Infosys Ltd	Q V+ PT	1,154	-7.09%	5,03,952 -	1,728 03 Feb, 26	1,215 17 Mar, 26	17.12	5.48	10.34	10.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Adani Power Ltd	Q V PT	213	-0.56%	4,13,175 -	217 23 Apr, 26	101 09 May, 25	40.27	8.28	22.06	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	ITC Ltd	Q V+ PT	302	-1.24%	3,82,650 -	444 27 May, 25	287 30 Mar, 26	19.08	5.19	13.47	4.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Oil & Natural Gas Corporation Ltd	Q V+ PT	285	-0.51%	3,60,048 -	293 02 Mar, 26	226 09 May, 25	11.01	1.05	4.58	14.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	HCL Technologies Ltd	Q V PT	1,203	-5.79%	3,46,589 -	1,770 03 Feb, 26	1,272 23 Apr, 26	20.83	4.61	11.43	9.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Bharat Electronics Ltd	Q V+ PT	445	-1.19%	3,28,830 -	473 06 Mar, 26	294 25 Apr, 25	55.26	14.37	37.66	23.76	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Hindustan Aeronautics Ltd	Q V+ PT	4,264	-2.02%	2,91,058 -	5,166 16 May, 25	3,479 30 Mar, 26	32.72	7.47	18.67	23.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Vedanta Ltd	Q V+ PT	721	-1.97%	2,87,648 -	795 21 Apr, 26	399 09 May, 25	20.29	6.56	8.47	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Bajaj Finserv Ltd	Q V+ PT	1,770	-1.20%	2,86,811 -	2,195 23 Oct, 25	1,598 02 Apr, 26	29.63	3.55	7.48	21.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Coal India Ltd	Q V PT	456	1.17%	2,77,693 -	476 13 Mar, 26	369 28 Aug, 25	9.30	2.47	5.13	16.16	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Nestle India Ltd	Q V PT	1,421	0.78%	2,71,902 -	1,424 22 Apr, 26	1,085 14 Aug, 25	76.71	51.21	50.61	9.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Bajaj Auto Ltd	Q V+ PT	9,576	0.26%	2,66,960 -	10,187 26 Feb, 26	7,556 09 May, 25	30.05	7.23	19.51	7.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Hindustan Zinc Ltd	Q V+ PT	589	-0.54%	2,50,160 -	733 28 Jan, 26	400 09 May, 25	21.40	14.30	12.99	9.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Indian Oil Corporation Ltd	Q V+ PT	143	-1.44%	2,05,464 -	189 27 Feb, 26	130 02 Apr, 26	6.29	1.03	5.04	2.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Eicher Motors Ltd	Q V PT	7,109	0.29%	1,94,441 -	8,233 27 Feb, 26	5,201 09 May, 25	36.29	8.34	27.60	20.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Interglobe Aviation Ltd	Q V PT	4,522	-0.73%	1,76,147 -	6,225 18 Aug, 25	3,895 23 Mar, 26	54.84	19.16	7.33	63.06	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Britannia Industries Ltd	Q V+ PT	5,732	1.09%	1,36,581 -	6,337 04 Sep, 25	5,280 02 May, 25	56.55	30.91	37.14	8.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Bharat Petroleum Corporation Ltd	Q V+ PT	308	-0.56%	1,34,407 -	392 05 Feb, 26	267 02 Apr, 26	5.76	1.35	3.16	27.81	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Tata Motors Passenger Vehicles Ltd	Q V+ PT	350	-0.48%	1,29,603 -	744 11 Jun, 25	294 30 Mar, 26	1.52	1.21	4.94	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Dr. Reddys Laboratories Ltd	Q V PT	1,316	-1.29%	1,11,264 Mid Cap	1,378 12 Jun, 25	1,121 07 May, 25	19.98	2.99	12.00	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Mazagon Dock Shipbuilders Ltd	Q V+ PT	2,679	-0.56%	1,08,679 Mid Cap	3,778 29 May, 25	2,057 30 Mar, 26	47.28	12.18	30.41	40.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Indus Towers Ltd	Q V PT	402	-0.64%	1,06,780 -	482 19 Feb, 26	313 03 Sep, 25	14.99	2.82	5.78	34.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	L&T Technology Services Ltd	Q V PT	3,381	-1.98%	36,561 Mid Cap	4,747 24 Dec, 25	3,047 12 Mar, 26	28.58	5.65	16.19	9.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Advantages of Investing in Magic Formula Stocks

Simple Yet Effective Strategy – The magic formula simplifies stock selection using earnings yield and return on capital (ROC), making it easy to follow.

Identifies Undervalued Stocks – Helps investors find high-quality companies at bargain prices, improving long-term returns.

Reduces Emotional Bias – A systematic approach eliminates impulsive decisions and market speculation.

Focuses on Strong Businesses – Prioritizes companies with high profitability and efficient capital use.

Proven Long-Term Performance – Works best when followed consistently for 5-10 years.

Annual Rebalancing for Optimization – Ensures a refreshed portfolio with the best opportunities.

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

News about Best Magic Formula Stocks 2026

Apr, 2026

Hindustan Zinc reports 68% jump in Q4FY26 consolidated net profit

Consolidated total income of the company increased by 48.42% at Rs 13,824.00 crore for Q4FY26

Apr, 2026

Life Insurance Corporation of India informs about change in management

Pursuant to Regulation 30 of the Listing Regulations, Life Insurance Corporation of India has informed that Varadarajan Muthuvenkataraman has been elevated to hold Senior Management Personnel (‘SMP’) position of the Corporation, as details enclosed. The details as required under Regulation 30 of the Listing Regulations read with circulars issued thereunder, from time to time, is enclosed as Annexure -1. A copy of this intimation is also being made available on the website of the Corporation at www.licindia.in.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

IndiGo commences daily direct flights between Mumbai, Jamnagar

The launch is part of IndiGo’s continued network expansion in Gujarat

Apr, 2026

Infosys declines despite its consolidated net profit grows 21% in Q4

The total consolidated income of the company increased by 12.93% at Rs 47,561 crore for Q4FY26

Apr, 2026

Dr. Reddy’s Laboratories informs about clarification on news item

With reference to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) regarding a news item appearing in ‘https://www.cnbctv18.com/’dated April 23, 2026 captioned ‘Dr. Reddy's Laboratories still awaiting approval for a major near-term trigger, sources say’. In this connection, Dr. Reddy’s Laboratories has informed that the above captioned news item headline is correct, as the Company has not yet received approval (‘Notice of Compliance’) for its Semaglutide Injection from Health Canada. Further it has informed that as part of the regulatory review process, the Company has received the ‘Drug Identification Numbers (DINs)’ for Semaglutide Injection from Health Canada on April 22, 2026. The company continue to engage constructively with the regulatory authority and remain committed to bringing the product to the Canadian market upon approval. In compliance with Regulation 30 of the SEBI Listing Regulations, the Company makes prompt disclosures, as and when any event or information is considered material or warrants such disclosure under the said Regulations. The company has informed that at this stage there is no material event/ information that requires disclosure under Regulation 30 of the SEBI Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

Infosys - Quaterly Results

The Revenue for the quarter ended March 2026 of Rs. 386410.00 millions grew by 13.20 % from Rs. 341360.00 millions.Net profit stood at Rs. 79750.00 millions compared to Rs. 66280.00 millions in the corresponding previous quarter,high by 20.32%.The company reported a good operating profit of 106110.00 millions compared to 97020.00 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	386410.00	341360.00	13.20	1488190.00	1365920.00	8.95	1488190.00	1365920.00	8.95
Other Income	10630.00	13230.00	-19.65	64910.00	47820.00	35.74	64910.00	47820.00	35.74
PBIDT	106110.00	97020.00	9.37	425040.00	382810.00	11.03	425040.00	382810.00	11.03
Interest	540.00	510.00	5.88	2070.00	2210.00	-6.33	2070.00	2210.00	-6.33
PBDT	105570.00	96510.00	9.39	411510.00	380600.00	8.12	411510.00	380600.00	8.12
Depreciation	6010.00	5900.00	1.86	23940.00	26190.00	-8.59	23940.00	26190.00	-8.59
PBT	99560.00	90610.00	9.88	387570.00	354410.00	9.36	387570.00	354410.00	9.36
TAX	19810.00	24330.00	-18.58	95460.00	98730.00	-3.31	95460.00	98730.00	-3.31
Deferred Tax	-1380.00	250.00	-652.00	-9130.00	-9630.00	-5.19	-9130.00	-9630.00	-5.19
PAT	79750.00	66280.00	20.32	292110.00	255680.00	14.25	292110.00	255680.00	14.25
Equity	20270.00	20760.00	-2.36	20270.00	20760.00	-2.36	20270.00	20760.00	-2.36
PBIDTM(%)	27.46	28.42	-3.38	28.56	28.03	1.91	28.56	28.03	1.91

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Best Magic Formula Stocks 2026

News about Best Magic Formula Stocks 2026

Hindustan Zinc reports 68% jump in Q4FY26 consolidated net profit

Life Insurance Corporation of India informs about change in management

IndiGo commences daily direct flights between Mumbai, Jamnagar

Infosys declines despite its consolidated net profit grows 21% in Q4

Dr. Reddy’s Laboratories informs about clarification on news item

Infosys - Quaterly Results

Track Now:

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Best Magic Formula Stocks 2026

News about Best Magic Formula Stocks 2026

Hindustan Zinc reports 68% jump in Q4FY26 consolidated net profit

Life Insurance Corporation of India informs about change in management

IndiGo commences daily direct flights between Mumbai, Jamnagar

Infosys declines despite its consolidated net profit grows 21% in Q4

Dr. Reddy’s Laboratories informs about clarification on news item

Infosys - Quaterly Results

Track Now:

Trending Blogs

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.